US FDA Publishes, Then Withdraws, PDUFA Rates Because Process ‘May Not Be Well Understood’
Executive Summary
User fees for NDAs including OTC switches were set to increase nearly 11% from FY2021 but could have gone even higher; a new notice will be issued but timing is unclear.